AbbVie
ABBV
1,636 hedge funds and large institutions have $65.6B invested in AbbVie in 2015 Q4 according to their latest regulatory filings, with 156 funds opening new positions, 604 increasing their positions, 674 reducing their positions, and 97 closing their positions.
61% more first-time investments, than exits
New positions opened: 156 | Existing positions closed: 97
9% more funds holding in top 10
Funds holding in top 10: 88 → 96 (+8)
6% more capital invested
Capital invested by funds: $61.7B → $65.6B (+$3.85B)
2% more funds holding
Funds holding: 1,604 → 1,636 (+32)
0.83% less ownership
Funds ownership: 68.84% → 68.01% (-0.83%)
10% less repeat investments, than reductions
Existing positions increased: 604 | Existing positions reduced: 674
20% less call options, than puts
Call options by funds: $739M | Put options by funds: $925M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$248M |
| 2 |
WIM
Woodford Investment Management
London,
United Kingdom
|
+$203M |
| 3 |
EIP
Epoch Investment Partners
New York
|
+$171M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$170M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$152M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$493M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$289M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$256M |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$204M |
| 5 |
Bank of New York Mellon
New York
|
-$198M |
ABBV Hedge Fund Activity: Q4 2015 in Review
1,636 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q4 2015, worth a combined $65.6B — up 6.2% from $61.7B a quarter earlier.
Buyers outnumbered sellers: 156 funds opened new ABBV positions and 97 closed out — a net gain of 59 holders — while 604 added to existing stakes and 674 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $248M. The largest seller was Morgan Stanley, cutting an estimated $493M.
- 1,636 institutional investors held AbbVie (ABBV) as of Q4 2015, up from 1,604 in Q3 2015.
- Funds reported $65.6B of AbbVie stock for Q4 2015, up 6.2% quarter-over-quarter.
- 156 funds opened new AbbVie positions in Q4 2015 and 97 closed out, a net change of +59 holders.
- The largest AbbVie buyer in Q4 2015 was Fidelity Investments, an estimated $248M added.
- The largest AbbVie seller in Q4 2015 was Morgan Stanley, an estimated $493M sold.
Based on aggregated 13F filings for Q4 2015.